News | December 08, 2014

High-Quality Hospitals Deliver Lowest-Cost Care for Congenital Heart Surgery Patients

Study finds costs of care differed by five-fold across 27 hospitals


December 8, 2014 — Children’s hospitals in the United States delivering the highest-quality care for children undergoing heart surgery also appear to provide care most efficiently at a low cost, according to research led by the University of Michigan and presented at the American Heart Association Scientific Sessions in Chicago.

Congenital heart defects are the most common birth defects, and each year more than 30,000 congenital heart operations are performed across U.S. children’s hospitals. Congenital heart defects are also one of the most expensive pediatric conditions to treat.

Given the many current initiatives in healthcare aimed at both improving quality of care and reducing costs, or optimizing value, University of Michigan researchers along with collaborators decided to study whether it is possible to deliver high-quality heart care but also at a low cost. The study’s lead author was Sara K. Pasquali, M.D., associate professor of pediatric cardiology within the Michigan Congenital Heart Center at U-M’s C.S. Mott Children’s Hospital and U-M’s Center for Healthcare Outcomes and Policy.

The researchers studied 30,670 patients ages 0-18 years undergoing heart surgery across 27 different hospitals, using a unique dataset of merged clinical and cost information from the Society of Thoracic Surgeons and Children’s Hospital Association.

According to Pasquali, costs of care differed by five-fold across these hospitals. The lowest-cost hospitals had significantly lower mortality rates compared to the other hospitals. The low-cost hospitals also had shorter lengths of stay after surgery and fewer post-operative complications.

Interestingly, the low-cost hospitals tended to be larger volume centers, who were able to achieve these outcomes despite treating a more high-risk patient population.

“The care of children with congenital heart conditions is complex and requires significant investment of resources. It has been unclear whether there are centers able to provide high quality care, but also at a low cost,” said Pasquali, who is a member of the Institute for Healthcare Policy and Innovation at U-M.

“Understanding these relationships is critical in the appropriate design of policies aiming to optimize healthcare value in this population and others. For example, one would not want to provide incentives to low-cost hospitals if these low costs were due to poor clinical outcomes, such as high rates of mortality.”

What this new research shows, Pasquali said, is that lower-cost hospitals seem to be doing the right thing: They are delivering the highest-quality care to children undergoing heart surgery.

“In addition, these results suggest that initiatives that aiming to improve quality of care and outcomes, may also hold the potential to reduce costs in this population she says.

For more information: www.mottchildren.org/congenital


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now